Roche Deploys 3,500 NVIDIA GPUs to Accelerate Global Drug Discovery

Roche is fundamentally changing pharmaceutical research by deploying more than 3,500 NVIDIA Blackwell GPUs across its global network.

This infrastructure shift moves artificial intelligence from experimental pilots to a core operational tool for researchers and manufacturing teams.

The systems span public cloud and physical data centers in the United States and Europe. Chief Digital and Technology Officer Wafaa Mamilli states the initiative leverages smarter AI to accelerate solutions for both pharma and diagnostic divisions.

Results are already emerging at Roche-owned Genentech. Their Lab-in-the-Loop strategy now integrates AI into nearly 90% of small-molecule programs. One oncology candidate was designed 25% faster than traditional methods.

Looking ahead, the company plans to use NVIDIA Omniverse for digital twins of manufacturing facilities. This technology will also support digital pathology to detect disease patterns with greater precision.